49 results
8-K
CKPT
Checkpoint Therapeutics Inc
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
(the “Purchase Agreement”) with a single healthcare-dedicated institutional investor. The Purchase Agreement provided for the sale and issuance
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
announced that it has entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate
8-K
EX-99.1
aoi12b3
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-99.1
tfkxi4 17sf
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-99.1
ba0p02kda
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
wglt5u
4 Nov 21
Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
4:44pm